financetom
Business
financetom
/
Business
/
Pfizer appoints James List to lead development of obesity medicines
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer appoints James List to lead development of obesity medicines
Mar 6, 2025 11:33 AM

March 6 (Reuters) - Pfizer ( PFE ) on Thursday named

James List as the head of the drugmaker's Internal Medicine

portfolio, which includes development of cardiovascular and

obesity medicines.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved